MX2007002903A - Metodos para el tratamiento de hemoptisis o hemorragias traqueales, bronquiales o alveolares, locales. - Google Patents

Metodos para el tratamiento de hemoptisis o hemorragias traqueales, bronquiales o alveolares, locales.

Info

Publication number
MX2007002903A
MX2007002903A MX2007002903A MX2007002903A MX2007002903A MX 2007002903 A MX2007002903 A MX 2007002903A MX 2007002903 A MX2007002903 A MX 2007002903A MX 2007002903 A MX2007002903 A MX 2007002903A MX 2007002903 A MX2007002903 A MX 2007002903A
Authority
MX
Mexico
Prior art keywords
hemoptysis
bronchial
methods
tracheal
treating local
Prior art date
Application number
MX2007002903A
Other languages
English (en)
Inventor
Lars Heslet
Lars Otto Uttenthal
Original Assignee
Pharmaorigin Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaorigin Aps filed Critical Pharmaorigin Aps
Publication of MX2007002903A publication Critical patent/MX2007002903A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Abstract

La presente invencion proporciona metodos para el tratamiento local de la hemorragia traqueal, bronquial, o alveolar, o la hemoptisis, y/o la reduccion de los efectos indeseables asociados con la administracion sistemica de los agentes tromboticos a un sujeto por medio de la administracion intratraqueal, intrabronquial o intraalveolar de un factor de coagulacion de la sangre al sujeto.
MX2007002903A 2004-09-10 2005-09-09 Metodos para el tratamiento de hemoptisis o hemorragias traqueales, bronquiales o alveolares, locales. MX2007002903A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60875904P 2004-09-10 2004-09-10
US62297704P 2004-10-28 2004-10-28
US69396905P 2005-06-24 2005-06-24
PCT/DK2005/000576 WO2006026998A1 (en) 2004-09-10 2005-09-09 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis

Publications (1)

Publication Number Publication Date
MX2007002903A true MX2007002903A (es) 2007-07-11

Family

ID=35482229

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007002903A MX2007002903A (es) 2004-09-10 2005-09-09 Metodos para el tratamiento de hemoptisis o hemorragias traqueales, bronquiales o alveolares, locales.

Country Status (13)

Country Link
US (2) US8431535B2 (es)
EP (1) EP1791555B1 (es)
JP (2) JP2008512403A (es)
KR (1) KR101241434B1 (es)
AU (1) AU2005282065B2 (es)
BR (1) BRPI0515163A (es)
CA (1) CA2579884C (es)
DK (1) DK1791555T3 (es)
HK (1) HK1104970A1 (es)
IL (1) IL181824A (es)
MX (1) MX2007002903A (es)
NO (1) NO20071824L (es)
WO (1) WO2006026998A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0515163A (pt) 2004-09-10 2008-07-08 Pharmaorigin Aps métodos para tratar hemoptise ou sangramento traqueal, brÈnquico ou alveolar local
RU2496515C2 (ru) * 2005-06-24 2013-10-27 Драгрекьюэ Апс Введение в дыхательные пути активированного белка с при воспалительных состояниях, поражающих дыхательные пути
US20070225749A1 (en) 2006-02-03 2007-09-27 Martin Brian B Methods and devices for restoring blood flow within blocked vasculature
ES2399138T3 (es) 2006-03-16 2013-03-26 Stellaris Pharmaceuticals Aps Tratamiento local con factor VII
EP2403583B1 (en) 2009-03-06 2016-10-19 Lazarus Effect, Inc. Retrieval systems
US20120141467A1 (en) * 2010-12-03 2012-06-07 Schneider Daniel J Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma
US9301936B2 (en) 2013-07-08 2016-04-05 Imprimis Pharmaceuticals, Inc. Pharmaceutical formulations of tranexamic acid and their use
WO2016130647A1 (en) 2015-02-11 2016-08-18 Lazarus Effect, Inc. Expandable tip medical devices and methods

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920845A (en) 1971-08-03 1975-11-18 Beecham Group Ltd 2-nitroindan-1,3-dione
US5096916A (en) 1990-05-07 1992-03-17 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
US5427797A (en) 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
US5690910A (en) 1995-08-18 1997-11-25 Baker Norton Pharmaceuticals, Inc. Method for treating asthma
US5980865A (en) 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
US5925738A (en) * 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
CA2278823A1 (en) 1997-01-29 1998-07-30 Joe M. Mccord Plasminogen activator as an anti-inflammatory agent
EE200000546A (et) * 1998-03-16 2002-02-15 Inhale Therapeutic Systems, Inc. Aerosoolistatud toimeaine manustamissüsteem
WO2000027360A1 (en) * 1998-11-10 2000-05-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Treatment set containing lungsurfactant compositions
AU5822801A (en) * 2000-05-10 2001-11-20 Novo Nordisk As Tharmaceutical composition comprising a factor viia and a factor xiii
US7419949B2 (en) * 2001-07-16 2008-09-02 Novo Noridsk Healthcare A/G Single-dose administration of factor VIIa
EP1446147A1 (en) * 2001-11-09 2004-08-18 Novo Nordisk Health Care AG Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid
WO2003066670A2 (en) 2002-02-04 2003-08-14 Salpep Biotechnology Inc. Dipeptides and tripeptides with anti-inflammatory activity
CN1838964A (zh) * 2002-04-25 2006-09-27 斯克里普斯研究学院 肺病的治疗与预防
PT1499719E (pt) * 2002-04-30 2011-02-09 Bayer Healthcare Llc Variantes polipeptídicas do factor vii ou viia
MXPA05010846A (es) 2003-04-09 2006-03-30 Nektar Therapeutics Tratamiento de hemofilia mediante inhalacion de factores de coagulacion.
US20040265238A1 (en) 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US7404957B2 (en) * 2003-08-29 2008-07-29 Aerovance, Inc. Modified IL-4 mutein receptor antagonists
BRPI0515163A (pt) 2004-09-10 2008-07-08 Pharmaorigin Aps métodos para tratar hemoptise ou sangramento traqueal, brÈnquico ou alveolar local

Also Published As

Publication number Publication date
US7807639B2 (en) 2010-10-05
US20070258971A1 (en) 2007-11-08
EP1791555B1 (en) 2013-03-13
WO2006026998A8 (en) 2006-05-04
CA2579884A1 (en) 2006-03-16
US8431535B2 (en) 2013-04-30
DK1791555T3 (da) 2013-06-10
BRPI0515163A (pt) 2008-07-08
HK1104970A1 (en) 2008-02-01
AU2005282065A1 (en) 2006-03-16
NO20071824L (no) 2007-04-10
KR20070067127A (ko) 2007-06-27
WO2006026998A1 (en) 2006-03-16
IL181824A (en) 2012-05-31
KR101241434B1 (ko) 2013-03-12
US20070060517A1 (en) 2007-03-15
AU2005282065B2 (en) 2013-02-07
JP2008512403A (ja) 2008-04-24
CA2579884C (en) 2013-12-31
JP2012092131A (ja) 2012-05-17
IL181824A0 (en) 2007-07-04
EP1791555A1 (en) 2007-06-06
JP5537537B2 (ja) 2014-07-02

Similar Documents

Publication Publication Date Title
MX2007002903A (es) Metodos para el tratamiento de hemoptisis o hemorragias traqueales, bronquiales o alveolares, locales.
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
MX349188B (es) Sns - 595 y metodos para utilizar el mismo.
UA98125C2 (ru) Замещенные дигидропиразолоны для лечения сердечно-сосудистых и гематологических заболеваний
GB2434983A (en) Methods and compositions for wound healing
EP2465923A3 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
MX2009006466A (es) Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
WO2007143607A3 (en) Method of treating atrophic vaginitis
HK1102366A1 (en) Factor ixa for the treatment of bleeding disorders
WO2010006219A3 (en) Use of scaffold comprising fibrin for delivery of stem cells
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
MX2010003548A (es) Metodos para el tratamiento de padecimientos neurologicos autoinmunes con ciclofosfamida.
WO2008079270A3 (en) Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
ZA200703166B (en) Composition comprising lactic acid and lactoferrin
SG196863A1 (en) Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
TW200507840A (en) Method of treating multiple myeloma
MX2008015775A (es) Compuestos y composiciones para tratamiento de cancer.
MY164998A (en) Isoquinolinone derivatives as nk3 antagonists
WO2007130501A3 (en) Combination therapy for treatment of cancer
HK1102626A1 (en) Compositions and methods for the treatment and prevention of hyperproliferative diseases
TW200503716A (en) Treatment of bacterial diseases of the respiratory organs
WO2009006246A8 (en) Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome
CA2787512C (en) A method of treating sinusitis, including chronic sinusitis
EA201070193A1 (ru) Лечение детских опухолей
MX2016005720A (es) Composiciones y metodos para administracion de una enzima a las vias respiratorias de un sujeto.

Legal Events

Date Code Title Description
FG Grant or registration